Major Depressive Disorder and Oxidative Stress: In Silico Investigation of Fluoxetine Activity against ROS

Major depressive disorder is a psychiatric disease having approximately a 20% lifetime prevalence in adults in the United States (U.S.), as reported by Hasin et al. in <i>JAMA Psichiatry</i> 2018 <i>75</i>, 336&#8722;346. Symptoms include low mood, anhedonia, decreased en...

Full description

Bibliographic Details
Main Authors: Cecilia Muraro, Marco Dalla Tiezza, Chiara Pavan, Giovanni Ribaudo, Giuseppe Zagotto, Laura Orian
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/9/17/3631
id doaj-9caf4eec54af4eff8504dc8925e656bf
record_format Article
spelling doaj-9caf4eec54af4eff8504dc8925e656bf2020-11-24T21:26:47ZengMDPI AGApplied Sciences2076-34172019-09-01917363110.3390/app9173631app9173631Major Depressive Disorder and Oxidative Stress: In Silico Investigation of Fluoxetine Activity against ROSCecilia Muraro0Marco Dalla Tiezza1Chiara Pavan2Giovanni Ribaudo3Giuseppe Zagotto4Laura Orian5Department of Chemical Sciences, University of Padova, Via Marzolo 1, 35131 Padova, ItalyDepartment of Chemical Sciences, University of Padova, Via Marzolo 1, 35131 Padova, ItalyDepartment of Medicine, University of Padova, Via Giustiniani 2, 35128 Padova, ItalyDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, ItalyDepartment of Pharmacological Sciences, University of Padova, Via Marzolo 5, 35131 Padova, ItalyDepartment of Chemical Sciences, University of Padova, Via Marzolo 1, 35131 Padova, ItalyMajor depressive disorder is a psychiatric disease having approximately a 20% lifetime prevalence in adults in the United States (U.S.), as reported by Hasin et al. in <i>JAMA Psichiatry</i> 2018 <i>75</i>, 336&#8722;346. Symptoms include low mood, anhedonia, decreased energy, alteration in appetite and weight, irritability, sleep disturbances, and cognitive deficits. Comorbidity is frequent, and patients show decreased social functioning and a high mortality rate. Environmental and genetic factors favor the development of depression, but the mechanisms by which stress negatively impacts on the brain are still not fully understood. Several recent works, mainly published during the last five years, aim at investigating the correlation between treatment with fluoxetine, a non-tricyclic antidepressant drug, and the amelioration of oxidative stress. In this work, the antioxidant activity of fluoxetine was investigated using a computational protocol based on the density functional theory approach. Particularly, the scavenging of five radicals (HO<sup>&#8226;</sup>, HOO<sup>&#8226;</sup>, CH<sub>3</sub>OO<sup>&#8226;</sup>, CH<sub>2</sub>=CHOO<sup>&#8226;</sup>, and CH<sub>3</sub>O<sup>&#8226;</sup>) was considered, focusing on hydrogen atom transfer (HAT) and radical adduct formation (RAF) mechanisms. Thermodynamic as well as kinetic aspects are discussed, and, for completeness, two metabolites of fluoxetine and serotonin, whose extracellular concentration is enhanced by fluoxetine, are included in our analysis. Indeed, fluoxetine may act as a radical scavenger, and exhibits selectivity for HO<sup>&#8226;</sup> and CH<sub>3</sub>O<sup>&#8226;</sup>, but is inefficient toward peroxyl radicals. In contrast, the radical scavenging efficiency of serotonin, which has been demonstrated in vitro, is significant, and this supports the idea of an indirect antioxidant efficiency of fluoxetine.https://www.mdpi.com/2076-3417/9/17/3631free radical scavengersantioxidantsfluoxetinedepressive disordermajoroxidative stressDFT calculationsreactive oxygen species
collection DOAJ
language English
format Article
sources DOAJ
author Cecilia Muraro
Marco Dalla Tiezza
Chiara Pavan
Giovanni Ribaudo
Giuseppe Zagotto
Laura Orian
spellingShingle Cecilia Muraro
Marco Dalla Tiezza
Chiara Pavan
Giovanni Ribaudo
Giuseppe Zagotto
Laura Orian
Major Depressive Disorder and Oxidative Stress: In Silico Investigation of Fluoxetine Activity against ROS
Applied Sciences
free radical scavengers
antioxidants
fluoxetine
depressive disorder
major
oxidative stress
DFT calculations
reactive oxygen species
author_facet Cecilia Muraro
Marco Dalla Tiezza
Chiara Pavan
Giovanni Ribaudo
Giuseppe Zagotto
Laura Orian
author_sort Cecilia Muraro
title Major Depressive Disorder and Oxidative Stress: In Silico Investigation of Fluoxetine Activity against ROS
title_short Major Depressive Disorder and Oxidative Stress: In Silico Investigation of Fluoxetine Activity against ROS
title_full Major Depressive Disorder and Oxidative Stress: In Silico Investigation of Fluoxetine Activity against ROS
title_fullStr Major Depressive Disorder and Oxidative Stress: In Silico Investigation of Fluoxetine Activity against ROS
title_full_unstemmed Major Depressive Disorder and Oxidative Stress: In Silico Investigation of Fluoxetine Activity against ROS
title_sort major depressive disorder and oxidative stress: in silico investigation of fluoxetine activity against ros
publisher MDPI AG
series Applied Sciences
issn 2076-3417
publishDate 2019-09-01
description Major depressive disorder is a psychiatric disease having approximately a 20% lifetime prevalence in adults in the United States (U.S.), as reported by Hasin et al. in <i>JAMA Psichiatry</i> 2018 <i>75</i>, 336&#8722;346. Symptoms include low mood, anhedonia, decreased energy, alteration in appetite and weight, irritability, sleep disturbances, and cognitive deficits. Comorbidity is frequent, and patients show decreased social functioning and a high mortality rate. Environmental and genetic factors favor the development of depression, but the mechanisms by which stress negatively impacts on the brain are still not fully understood. Several recent works, mainly published during the last five years, aim at investigating the correlation between treatment with fluoxetine, a non-tricyclic antidepressant drug, and the amelioration of oxidative stress. In this work, the antioxidant activity of fluoxetine was investigated using a computational protocol based on the density functional theory approach. Particularly, the scavenging of five radicals (HO<sup>&#8226;</sup>, HOO<sup>&#8226;</sup>, CH<sub>3</sub>OO<sup>&#8226;</sup>, CH<sub>2</sub>=CHOO<sup>&#8226;</sup>, and CH<sub>3</sub>O<sup>&#8226;</sup>) was considered, focusing on hydrogen atom transfer (HAT) and radical adduct formation (RAF) mechanisms. Thermodynamic as well as kinetic aspects are discussed, and, for completeness, two metabolites of fluoxetine and serotonin, whose extracellular concentration is enhanced by fluoxetine, are included in our analysis. Indeed, fluoxetine may act as a radical scavenger, and exhibits selectivity for HO<sup>&#8226;</sup> and CH<sub>3</sub>O<sup>&#8226;</sup>, but is inefficient toward peroxyl radicals. In contrast, the radical scavenging efficiency of serotonin, which has been demonstrated in vitro, is significant, and this supports the idea of an indirect antioxidant efficiency of fluoxetine.
topic free radical scavengers
antioxidants
fluoxetine
depressive disorder
major
oxidative stress
DFT calculations
reactive oxygen species
url https://www.mdpi.com/2076-3417/9/17/3631
work_keys_str_mv AT ceciliamuraro majordepressivedisorderandoxidativestressinsilicoinvestigationoffluoxetineactivityagainstros
AT marcodallatiezza majordepressivedisorderandoxidativestressinsilicoinvestigationoffluoxetineactivityagainstros
AT chiarapavan majordepressivedisorderandoxidativestressinsilicoinvestigationoffluoxetineactivityagainstros
AT giovanniribaudo majordepressivedisorderandoxidativestressinsilicoinvestigationoffluoxetineactivityagainstros
AT giuseppezagotto majordepressivedisorderandoxidativestressinsilicoinvestigationoffluoxetineactivityagainstros
AT lauraorian majordepressivedisorderandoxidativestressinsilicoinvestigationoffluoxetineactivityagainstros
_version_ 1725977549910048768